- Home
- TNL vs SLNO Comparison
TNL vs SLNO Comparison
Compare TNL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNL
- SLNO
- Stock Information
- Founded
- TNL 1990
- SLNO 1999
- Country
- TNL United States
- SLNO United States
- Employees
- TNL N/A
- SLNO N/A
- Industry
- TNL Hotels/Resorts
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TNL Consumer Discretionary
- SLNO Health Care
- Exchange
- TNL Nasdaq
- SLNO Nasdaq
- Market Cap
- TNL 3.3B
- SLNO 3.8B
- IPO Year
- TNL N/A
- SLNO 2014
- Fundamental
- Price
- TNL $61.80
- SLNO $52.75
- Analyst Decision
- TNL Buy
- SLNO Strong Buy
- Analyst Count
- TNL 10
- SLNO 10
- Target Price
- TNL $62.30
- SLNO $112.50
- AVG Volume (30 Days)
- TNL 609.2K
- SLNO 1.9M
- Earning Date
- TNL 10-22-2025
- SLNO 11-05-2025
- Dividend Yield
- TNL 3.54%
- SLNO N/A
- EPS Growth
- TNL N/A
- SLNO N/A
- EPS
- TNL 5.78
- SLNO N/A
- Revenue
- TNL $3,915,000,000.00
- SLNO $32,656,999.00
- Revenue This Year
- TNL $4.17
- SLNO N/A
- Revenue Next Year
- TNL $4.22
- SLNO $175.39
- P/E Ratio
- TNL $10.94
- SLNO N/A
- Revenue Growth
- TNL 2.46
- SLNO N/A
- 52 Week Low
- TNL $37.77
- SLNO $41.50
- 52 Week High
- TNL $64.12
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- TNL 53.31
- SLNO 24.40
- Support Level
- TNL $61.31
- SLNO $50.63
- Resistance Level
- TNL $63.63
- SLNO $72.99
- Average True Range (ATR)
- TNL 1.12
- SLNO 4.32
- MACD
- TNL -0.16
- SLNO -1.06
- Stochastic Oscillator
- TNL 26.43
- SLNO 9.34
About TNL Travel Leisure Co. Common Stock
Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.